Skip to content

Clinical trials

Glaucoma trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glaucoma Phase: Not applicable Status: Unknown status Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20053
20063
20072
20081
20092
20101
20115
20124
20132
20142
20153
201610
20175
201810
20194
20209
202110
202213
202315
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4
Zhongshan Ophthalmic Center, Sun Yat-sen University4
Centre hospitalier de l'Université de Montréal (CHUM)3
Federal University of São Paulo3
Benha University2
Cairo University2
China Medical University Hospital2
First Affiliated Hospital of Fujian Medical University2
Fondation Hôpital Saint-Joseph2
Glaukos Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glaucoma107
Glaucoma, Open-Angle15
Ocular Hypertension10
Cataract6
Macular Degeneration6
Diabetic Retinopathy5
Glaucoma, Angle-Closure5
Anxiety Disorders3
Diabetes Mellitus3
Eye Diseases3

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.